Larvol Delta - Chengdu-Origen-and-Vanotech-Announce-First-Patient-Dosed-in-VAN2401-Phase-1-Trial-of-Gene-Therapy-for-Wet-AgeRelated-Macular-Degeneration

KH658 - Chengdu Kanghong Pharma

https://www.globenewswire.com/news-release/2025/05/02/3073105/0/en/Chengdu-Origen-and-Vanotech-Announce-First-Patient-Dosed-in-VAN-2401-Phase-1-Trial-of-Gene-Therapy-for-Wet-Age-Related-Macular-Degeneration.html

May 2, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next